Within the CD27+ IFNγ-producing γδ T-cell subset, there appears to be some nuance, as Vγ4+ cells are better at restraining B16 melanoma tumors than Vγ1+ cells (He et al, 2010). This evidence concerns the gene CD27 and melanoma.